Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
- First Posted Date
- 2007-01-17
- Last Posted Date
- 2013-03-14
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 90
- Registration Number
- NCT00423007
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Pediatric Zylet Safety and Efficacy Study
Phase 4
Completed
- Conditions
- ChalazionHordeolum
- Interventions
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2011-10-07
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 108
- Registration Number
- NCT00420628
- Locations
- 🇺🇸
Pediatric Ophthalmology of Erie, Erie, Pennsylvania, United States
Systemic Pharmacokinetics of BOL-303224-A
- First Posted Date
- 2006-12-05
- Last Posted Date
- 2011-12-09
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 24
- Registration Number
- NCT00407589
- Locations
- 🇺🇸
Cornerstone Eyecare, High point, North Carolina, United States
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants
Phase 2
Completed
- Conditions
- Noninfectious Posterior Uveitis
- Interventions
- First Posted Date
- 2006-12-04
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 278
- Registration Number
- NCT00407082
- Locations
- 🇺🇸
Duke Eye Center, Durham, North Carolina, United States
A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis
Phase 2
Withdrawn
- Conditions
- Allergic Conjunctivitis
- First Posted Date
- 2006-09-13
- Last Posted Date
- 2015-02-20
- Lead Sponsor
- Bausch & Lomb Incorporated
- Registration Number
- NCT00375596
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
- First Posted Date
- 2006-09-01
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 162
- Registration Number
- NCT00370747
A Study to Investigate the Safety and Effectiveness of Aspheric Laser Refractive Surgery Treatments for Myopia
Not Applicable
Completed
- Conditions
- MyopiaAstigmatism
- Interventions
- Device: The Bausch & Lomb Zyoptix Tissue Saving Aspheric algorithmDevice: The Bausch & Lomb Zyoptix Tissue Saving algorithm
- First Posted Date
- 2006-08-17
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 127
- Registration Number
- NCT00365677
A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Device: Next Generation Diagnostic Instrument (NGDI)Device: Zyoptix Diagnostic Workstation (ZDW)
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2014-01-17
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 76
- Registration Number
- NCT00347594
- Locations
- 🇺🇸
Bausch & Lomb, Rochester, New York, United States
Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2019-06-21
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 29
- Registration Number
- NCT00348439
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2015-03-24
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 957
- Registration Number
- NCT00347932
© Copyright 2025. All Rights Reserved by MedPath